Can We Reliably Needle Hip Muscles Blindly?
ConditionHip Needling
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorErzurum Regional Training & Research Hospital
About this trial
The aim of this study is to evaluate the accuracy of invasive interventions (dry needling or injection) performed on specific muscles of the hip region in reaching the anatomical target. The accuracy of the interventions performed with a blinded method will be compared with an observational assessment supported by ultrasonography. The interventions will be performed by a physician with clinical experience, and the anatomical location of the needle tip will be evaluated by a second physician with ultrasonography after each procedure. The targeted muscles include the iliacus, pectineus, sartorius, tensor fascia latae, and rectus femoris. Each participant will be subjected to interventions for five different muscles, and a total of at least 40 injection interventions will be analyzed. Ultrasonography will be used only for observation and verification purposes; no pharmacological substances will be applied during the procedure. All procedures will be performed under sterile conditions, and participants will be monitored for 24 hours for possible pain, bruising, or complications. Participants will be informed about the content and purpose of the study, and written informed consent forms will be obtained. The study does not have a therapeutic purpose and is only intended to investigate targeting accuracy. The data to be obtained is expected to contribute to the determination of anatomical accuracy rates in clinical practices and the improvement of interventional training processes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18 to 65 years
Individuals with nonspecific hip, groin, or anterior thigh pain who are scheduled for physical therapy
Clinical suspicion of myofascial pain syndrome, particularly involving muscles around the hip
Patients with clinical indication for dry needling or similar invasive treatments (e.g., targeting muscles such as iliacus, pectineus, sartorius)
Disqualifiers
Use of anticoagulant medications (due to increased risk of bleeding)
Severe hip osteoarthritis, presence of hip prosthesis, history of previous hip surgery, or significant anatomical deformity
Active infection or skin lesion at the planned injection site
Inability to cooperate or communicate effectively
Trial design
Design model
Single group
Treatments tested in this trial
Blinded Dry Needling
Procedure/SurgeryDry needling is performed using anatomical landmarks without ultrasound guidance. Needle placement is then confirmed via ultrasound imaging.
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: Blind Dry Needling Lumbar Paraspinal MusclesExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Accuracy of Blinded Dry Needling Injections
Proportion of injection attempts in which the needle accurately reaches the intended target muscle using the blinded (anatomical landmark-based) technique, as confirmed by ultrasonography.
Time frame
Immediately after each injection attemptSecondary outcomes
1
Accuracy Rate per Target Muscle
Determination of individual accuracy rates for each of the five specific muscles injected using the blinded technique (e.g., iliacus, pectineus, sartorius, etc.), based on ultrasound confirmation.
Time frame
Immediately after each injection attemptOther outcomes
1
Inter-Operator Variability in Injection Accuracy
Evaluation of variability in injection accuracy among different clinicians performing the blinded technique, based on ultrasound-confirmed needle placements.
Time frame
2 weekLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: